News
Investment
Lifestyle
Videos
Search for:
Search
More
Contact
Features
News
Home
Biotech
Investment
Diagnostics
Agetech
Supplements
Innovation
AI/Digital
Economy
Biotech
The small molecule with a big future
Biotech
Researchers identify small molecule that restores visual function after optic nerve injury
Biotech
Telocyte’s gene therapy funded through to clinical trials
Michael Fossel on securing new investment, taking telomerase gene therapy to the clinic, and its potential in cardiovascular disease.
Biotech
Hypertension drug rilmenidine can extend lifespan and slow aging
Biotech
Humacyte publishes 6-year outcomes in Phase 2 study of its Human Acellular Vessel
Biotech
HRT could ward off Alzheimer’s disease in at-risk women
Biotech
Rapamycin – the most promising life extension drug?
Biotech
Making a noise about the silent killer
Biotech
AmyriAD’s Alzheimer’s drug ready for Phase 3 trials
Biotech
Cyclarity’s guardians are leading the battle against atherosclerosis
Biotech
Alzheimer’s drug lecanemab granted Accelerated Approval from FDA
Biotech
Longevity biotech: ‘This is still just the beginning’
Biotech
Biosplice announces data from osteoarthritis clinical trial – and the initiation of new phase 3 trial
Biotech
Harnessing the potential of regenerative stem cell secretomes in age-related disease
Biotech
Innovative atherosclerosis treatment readies for clinical trials
Biotech
Kristen Fortney on the pathway to longevity
Biotech
Innovative cancer treatment device has longevity potential
Biotech
Antiaging drug rapamycin might only benefit females, new research shows
Biotech
Genflow builds on SIRT6 research with new patent
Biotech
Cellular ‘glue’ can regenerate tissues, heal wounds and regrow nerves
Biotech
Rise of the WormBots: it’s time to scale up longevity R&D
Biotech
Tick, tock… funding calls for both aging clocks and psychedelics and longevity grant proposals
Biotech
Do mitochondria hold the key to a Parkinson’s breakthrough?
Biotech
Time to Turn the other cheek
Biotech
BioAge announces positive topline results for clinical trial evaluating muscle atrophy
Biotech
Cajal Neuroscience launches with $96 million to transform neurodegeneration drug discovery
Biotech
Eisai-Biogen Alzheimer’s drug slows cognitive decline – but safety concerns persist
Biotech
Is aging a question of order vs disorder?
Biotech
Clinical trial death raises safety concerns about promising Alzheimer’s therapy
Biotech
New small molecule drug for lowering cholesterol
Biotech
Constructively disruptive – tackling atherosclerosis through disease reversal
Biotech
Juvena Therapeutics bags $41 million to accelerate biologics for age-related diseases
Biotech
Load More